Precise regulation of nuclear factor kB (NF-kB) signaling is crucial for normal immune responses, and defective NF-kB activity underlies a range of immunodeficiencies. NF-kB is activated through two signaling cascades: the classical and noncanonical pathways. The classical pathway requires inhibitor of kB kinase b (IKKb) and NF-kB essential modulator (NEMO), and hypomorphic mutations in the gene encoding NEMO (ikbkg) lead to inherited immunodeficiencies, collectively termed NEMO-ID. Noncanonical NF-kB activation requires NF-kB-inducing kinase (NIK) and IKKa, but not NEMO. We found that noncanonical NF-kB was basally active in peripheral blood mononuclear cells from NEMO-ID patients, and that noncanonical NF-kB signaling was similarly enhanced in cell lines lacking functional NEMO. NIK, which normally undergoes constitutive degradation, was aberrantly present in resting NEMOdeficient cells, and regulation of its abundance was rescued by reconstitution with full-length NEMO, but not a mutant NEMO protein unable to physically associate with IKKa or IKKb. Binding of NEMO to IKKa was not required for ligand-dependent stabilization of NIK or noncanonical NF-kB signaling. Rather, an intact and functional IKK complex was essential to suppress basal NIK activity in unstimulated cells. Despite interacting with IKKa and IKKb to form an IKK complex, NEMO mutants associated with immunodeficiency failed to rescue classical NF-kB signaling or reverse the accumulation of NIK. Together, these findings identify a crucial role for classical NF-kB activity in the suppression of basal noncanonical NF-kB signaling.
INTRODUCTION
Members of the nuclear factor kB (NF-kB) family of inducible transcription factors play key roles in normal immune system development and function, cell survival, and cellular homeostasis (1) . Aberrant activation of NF-kB underlies the pathogenesis of many inflammatory diseases and cancers (2) , and failure to activate NF-kB is associated with immunodeficiency (3) . Two major mechanisms of NF-kB activation that regulate distinct subsets of genes have been described: the classical and noncanonical NF-kB pathways. A wide range of stimuli, including proinflammatory cytokines and the ligation of innate and adaptive immune receptors, activate the classical NF-kB pathway (1) . Signals initiated by these diverse stimuli converge on the heterotrimeric inhibitor of kB kinase (IKK) complex, which contains IKKa, IKKb, and the noncatalytic regulatory subunit NF-kB essential modulator (NEMO, also known as IKKg) (4) . Activation of the IKK complex leads to the phosphorylation, ubiquitylation, and proteasomal degradation of members of the inhibitor of kB (IkB) family of proteins that sequester NF-kB in the cytoplasm of resting cells. Degradation of IkB enables the nuclear translocation of NF-kB homo-or heterodimers to regulate the expression of genes involved in diverse cellular responses (1) . Genetic studies have established that classical NF-kB signaling absolutely requires NEMO and predominantly the catalytic activity of IKKb to phosphorylate IkBa (5) (6) (7) (8) (9) (10) (11) . For most inducers of classical signaling, IKKa is not required for the phosphorylation of IkBa, but instead plays a less well-defined role in classical NF-kB-dependent gene transcription (12) (13) (14) (15) ; IKKa is also important for the termination of classical NF-kB-dependent transcription of target genes in macrophages (16) .
IKKa is required for the activation of noncanonical NF-kB signaling (17, 18) in response to the stimulation of receptors for the tumor necrosis factor (TNF) superfamily of cytokines, including the lymphotoxin-b receptor (LTbR), CD40, B cell-activating factor receptor (BAFF-R or TNFRSF13C), TNF-related weak inducer of apoptosis (TWEAK) receptor (also known as TNFRSF12A, Fn14, or CD266), and receptor activator of NF-kB (RANK, also known as TNFRSF11A) (19) . Activation of these receptors leads to the IKKa-mediated phosphorylation of the NF-kB precursor protein p100, which associates with and sequesters another NF-kB subunit, RelB, in the cytoplasm of resting cells. IKKa-mediated phosphorylation of p100 facilitates its proteasomal processing to p52 and the release of p52-RelB heterodimers to the nucleus. Noncanonical NF-kB signaling regulates the expression of a small panel of genes, including cxcl12, cxcl13, ccl19, ccl21, and tnfsf13b, whose products are crucial for lymph node organogenesis and B cell homeostasis (20) . Analyses of NF-kB signaling in cells lacking individual IKKs have established that p100 processing can be induced in the absence of either NEMO or IKKb (17, 18, 21) . Thus, it is thought that IKKa alone is necessary for the regulation of noncanonical NF-kB signaling.
Activation of the noncanonical NF-kB signaling pathway also requires the catalytic activity of NF-kB-inducing kinase (NIK) (22) . In resting cells, newly synthesized NIK protein is rapidly degraded by a complex consisting of TNF receptor-associated factor 2 (TRAF2), TRAF3, cellular inhibitor of apoptosis 1 (cIAP1), and cIAP2 (23) (24) (25) (26) , and upon activation of an appropriate receptor, for example LTbR, NIK is freed from this complex and accumulates in the cytoplasm (23) (24) (25) . Stabilized NIK phosphorylates and activates IKKa, which leads to p100 processing and noncanonical NF-kB activation. IKKa also phosphorylates active NIK to stimulate its degradation (27) . The precise phosphorylation-dependent mechanism of NIK turnover is unclear, but this negative feedback loop is crucial to eliminate NIK and terminate noncanonical NF-kB signaling.
Noncanonical NF-kB plays a key role in immunoglobulin (Ig) classswitch recombination in activated B cells to generate the IgA isotype (28) . Prolonged stability of NIK enhances noncanonical NF-kB signaling, and mice with increased NIK abundance display high serum concentrations of IgA (28) . Notably, a subset of patients with inherited mutations in NEMO exhibits increased amounts of IgA, a condition known as hyper-IgA syndrome (29) . These patients have a complex immunodeficiency termed NEMO-ID, which is a result of defects in classical NF-kB signaling; however, the mechanisms underlying the unusual clinical presentation of hyper-IgA have not been explained by the lack of classical NF-kB activity (29) . Here, we showed that noncanonical NF-kB signaling was enhanced in resting peripheral blood mononuclear cells (PBMCs) from NEMO-ID patients and in cell lines lacking functional NEMO. Our findings define a crucial role for the intact classical IKK complex and classical NF-kB signaling in the regulation of basal NIK abundance to maintain the quiescent state of the noncanonical NF-kB pathway.
RESULTS

NEMO inhibits the noncanonical NF-kB signaling pathway
To assess the status of the noncanonical NF-kB pathway in samples from NEMO-ID patients previously shown to have impaired classical NF-kB activation and increased concentrations of serum IgA (29, 30), we compared p100 processing in unstimulated PBMCs from two patients to that in PBMCs from a healthy donor. The abundance of p52 in comparison to the abundance of p100 was greater in the PBMCs of both of the NEMO-ID patients (Q403X and C417R) than in the PBMCs of the healthy donor or in human umbilical vein endothelial cells (HUVECs) stimulated with the TNF superfamily member LIGHT (also known as TNFSF14) (31) (Fig. 1A) . We did not detect p100 protein in PBMCs from a patient with the Q403X mutation, suggesting that cellular p100 was completely processed to p52 in these cells. These data indicate that basal noncanonical NF-kB signaling was enhanced in the context of NEMO-ID.
To understand how NEMO affected noncanonical NF-kB signaling, we examined basal and LIGHT-induced p100 processing in NEMO-deficient (NEMO KO ) mouse embryonic fibroblasts (MEFs). Basal p100 processing was substantially increased in resting (unstimulated) NEMO KO MEFs compared to that in resting wild-type MEFs (Fig. 1B and fig. S1A ). Consistent with earlier studies (17, 18, 21) , p100 processing in NEMO KO MEFs was further enhanced in response to LIGHT or an agonistic LTbR antibody (Fig. 1B and fig. S1 , B and C); however, in some experiments, basal amounts of p52 protein were already maximal in NEMO-deficient cells and were not further increased in response to activating ligands ( fig. S1 , B and C).
To further examine the activation status of noncanonical NF-kB signaling in the absence of NEMO, we analyzed cytoplasmic and nuclear fractions from resting and anti-LTbR-stimulated MEFs by Western blotting. We found that p52 was absent from the nuclear samples of unstimulated wild-type and IKKa KO MEFs (Fig. 1C) and, as expected, that the LTbR antibody stimulated the nuclear translocation of p52 in wild-type, but not IKKa KO , cells. Consistent with the enhanced processing of p100 in cells lacking NEMO (Fig. 1B and fig. S1 ), nuclear p52 was present in unstimulated NEMO KO MEFs and was increased in abundance in response to activation of LTbR (Fig. 1C and fig. S2A ). Furthermore, more nuclear RelB was present in resting NEMO KO MEFs than in unstimulated wild-type and IKKa KO cells, and the extent of RelB nuclear translocation was markedly enhanced by LTbR antibody (Fig. 1C and fig. S2A ). These data reveal that the basal amounts of p52 and RelB in the nuclei of resting NEMO KO MEFs were similar to those in wild-type cells stimulated through LTbR ( fig. S2A ). Consistent with the increased amounts of nuclear p52 and RelB, transcription of the noncanonical NF-kB gene target cxcl12 (18, 31, 32) was substantially increased in unstimulated NEMO KO MEFs compared to that in resting wild-type cells ( fig. S2B ). Together, these findings indicate that the noncanonical NF-kB signaling pathway is active in NEMO KO MEFs. To confirm that these findings were not unique to MEFs, we assessed p100 processing in the Jurkat T cell line 8321, which contains a hypomorphic NEMO fragment that only retains partial function (33) . As in the NEMO-ID PBMCs and NEMO KO MEFs (Fig. 1 ), p52 protein abundance 
NIK is present in cells that lack NEMO
Noncanonical NF-kB activation requires ligand-induced stabilization of NIK (17, 18, 34) . Because genetic loss of NEMO resulted in the increased processing of p100 (Fig. 1) , we asked whether NIK protein amounts were also dysregulated in the absence of NEMO. As expected, NIK was undetected in resting wild-type MEFs, but was stabilized in response to LIGHT ( Fig. 2A) . Consistent with the recently reported role for IKKa in mediating NIK turnover (27) , NIK was present in unstimulated IKKa-deficient cells, and its abundance was further increased in response to LIGHT (Fig. 2A) .
NIK was also present in resting NEMO KO MEFs ( Fig. 2A) , and its abundance was either unchanged or minimally enhanced in response to LIGHT. Despite the presence of a substantially increased amount of NIK protein in NEMO KO MEFs compared to that in wild-type MEFs (Fig. 2B ), quantitative reverse transcription polymerase chain reaction (RT-PCR) assays showed that the abundance of map3k14 mRNA was similar in wild-type, IKKa KO , and NEMO KO cells (Fig. 2C) , indicating that the increased amount of NIK protein in NEMO-deficient MEFs was not a result of increased expression of map3k14, which encodes NIK.
We next analyzed NIK in NEMO-mutant 8321 cells, which exhibited enhanced processing of p100 ( fig. S3 ). The amount of NIK in unstimulated NEMO-mutant 8321 cells was markedly increased compared to that in unstimulated parental 3T8 cells (Fig. 2D) . Similarly, NIK abundance was increased in resting NEMO-deficient Rat5R fibroblasts compared to that in parental Rat1 cells (Fig. 2E) (35) . Stimulation of wild-type MEFs with LIGHT led to transient stabilization of NIK and processing of p100 (Fig. 3A) . Consistent with previous reports (27) , NIK was detected in IKKa KO cells that were transduced with retrovirus containing the control MigR1 plasmid and was further stabilized in response to LIGHT (Fig. 3A) . Reconstitution of IKKa KO cells with either IKKa WT or IKKa DNBD resulted in NIK becoming undetectable under resting conditions. In addition, stimulation of either IKKa WT or IKKa DNBD MEFs with LIGHT induced the stabilization of NIK and processing of p100 to generate p52 (Fig. 3A) . Thus, we conclude that the association of NEMO with IKKa is dispensable for regulating basal NIK abundance, and that binding to NEMO is not required for IKKa to regulate p100 processing in response to LIGHT.
We next questioned whether the association of IKKa with NEMO was required for the IKKa-dependent turnover of active NIK. To address this, we incubated MEFs with LIGHT for 4 hours to stabilize NIK and then incubated the cells with cycloheximide for up to 1 hour to prevent new protein synthesis before visualizing NIK turnover by Western blotting. Supporting the model of IKKa-dependent feedback regulation (27) , LIGHT-induced NIK protein was rapidly lost in wild-type MEFs, whereas NIK in IKKa-deficient cells remained detectable 60 min after incubation with cycloheximide ( Fig. 3B) . Furthermore, both IKKa WT and IKKa DNBD restored NIK turnover in IKKa KO cells, which demonstrated that the ability of active IKKa to destabilize LIGHT-induced NIK protein (27) was independent of its association with NEMO (Fig. 3B) . The aberrant stabilization of NIK in unstimulated NEMO-deficient cells was therefore not a result of the loss of the NEMO-IKKa interaction.
The IKK complex is required for the regulation of basal NIK abundance
Because dissociation of NEMO from IKKa alone did not affect the basal extent of p100 processing or NIK stability (Fig. 3 ), our earlier findings ( Fig. 2F ) led us to ask whether IKKb might be involved in the NEMOdependent control of NIK abundance. To address this, we examined noncanonical NF-kB signaling in resting IKKbdeficient (IKKb KO ) MEFs and found that, similar to the situation in NEMO KO cells, basal p52 abundance was increased (Fig. 4A) . Consistent with previous reports (18) , p100 processing in IKKb KO MEFs was further enhanced by LIGHT, confirming that ligandinduced, noncanonical NF-kB signaling was intact in the absence of IKKb (Fig. 4A ). Similar to that in NEMO KO cells, NIK abundance was substantially increased in resting IKKb KO MEFs compared to that in wildtype cells, and treatment with LIGHT or anti-LTbR led to additional stabilization of NIK ( Fig. 4B and fig. S6A ). Examination of a second independently generated IKKb KO S7C ), suggesting that increased NIK abundance was required for the robust activation of IKKa seen in these cells. Collectively, these findings suggest that basal regulation of the noncanonical NF-kB signaling pathway requires the intact and catalytically active IKK complex.
NIK is phosphorylated in cells lacking NEMO or IKKb
The recently described negative feedback loop that leads to the degradation of NIK requires the phosphorylation of NIK by IKKa (27) . This mechanism prevents prolonged noncanonical NF-kB signaling, and can be monitored by the detection of a single band corresponding to unphosphorylated NIK in IKKa KO MEFs (Fig. 4B) . Because the band corresponding to NIK that we detected in cells lacking NEMO or IKKb resembled that detected in wild-type MEFs stimulated by LIGHT or LTbR antibody (Fig. 4B) , we reasoned that this slower-migrating band corresponded to phosphorylated NIK. Treatment of LIGHT-stimulated MEFs with l-phosphatase caused NIK in wild-type, NEMO KO , and IKKb KO cells to migrate with the same electrophoretic mobility as that of unphosphorylated NIK in IKKa KO MEFs (Fig. 5A) . Moreover, l-phosphatase reduced the apparent molecular mass of stabilized NIK in TRAF3 KO MEFs, in which basal degradation of NIK is defective (Fig. 5B) (36) . These data suggest that active NIK is phosphorylated by IKKa in MEFs lacking NEMO, IKKb, or TRAF3, similar to that in wild-type cells.
Because our results suggest that both IKKa and IKKb are required for the overall regulation of NIK abundance, we assessed NIK protein stability S8B ). These data demonstrate that NIK is phosphorylated in an IKKa-dependent manner in cells lacking either NEMO or IKKb.
IKKa-mediated turnover of NIK is independent of the IKK complex
Our accumulated findings establish that NIK is present and phosphorylated by IKKa under resting conditions in NEMO-or IKKb-deficient MEFs. Because NIK in these resting cells resembled NIK in ligand-stimulated wild-type MEFs (Fig. 5A) , we asked whether the intact IKK complex was required for the IKKa-dependent degradation of active NIK (27) . Consistent with the inducible activation of the noncanonical pathway in NEMO KO and IKKb KO cells, NIK abundance was enhanced in these cells in response to LIGHT, and this active NIK was degraded with similar kinetics to that of NIK in wild-type MEFs (Fig. 5C ). As expected, NIK remained stable in DKO MEFs in the presence of cycloheximide, which confirmed that negative feedback in the absence of the intact IKK complex required IKKa. Furthermore, activation-induced turnover of NIK was independent of the basal NIK regulatory complex, because active NIK in
TRAF3
KO cells was degraded similarly to NIK in wild-type, NEMO KO , and IKKb KO MEFs (Fig. 5C ). These data indicate the intact IKK complex is not required for the IKKa-mediated turnover of activated NIK.
We next questioned whether the IKKa-phosphorylated NIK present in resting NEMO KO and IKKb KO MEFs resulted from defective protein turnover. We found that treatment of unstimulated NEMO KO and IKKb
KO
MEFs with cycloheximide led to loss of basal NIK (Fig. 5D ). In contrast, unphosphorylated NIK in both resting IKKa KO and DKO cells was stable and remained detectable 2 hours after treatment with cycloheximide (Fig.  5D) . Thus, these data suggest that the IKK complex does not regulate IKKa-mediated NIK turnover, but instead plays an obligate role in limiting the basal pool of newly synthesized NIK. Classical NF-kB activity is required for the regulation of basal NIK abundance
To determine whether the IKK complex regulated NIK abundance through classical, NF-kB-driven transcription, we assessed noncanonical NF-kB activity in MEFs lacking the prototypic classical NF-kB subunit p65 (p65 KO ). Similar to unstimulated NEMO KO and IKKb KO MEFs, NIK was increased in abundance in p65 KO MEFs before stimulation with LIGHT or LTbR antibody (Fig. 6A) . Quantitative RT-PCR analysis of p65 KO MEFs showed that classical NF-kB signaling did not control map3k14 expression directly (Fig. 6B) . Consistent with experiments with NEMO KO and IKKb KO MEFs (Fig. 5A) , treatment with l-phosphatase revealed that active NIK was phosphorylated in p65 KO MEFs (Fig. 6C) . Furthermore, the normal reduced abundance of NIK in resting cells was partially restored by stable reconstitution of p65 KO MEFs with wild-type p65 (Fig. 6D) .
Because classical NF-kB activity did not directly affect the expression of map3k14 (Figs. 2C and 6B) , we sought to determine whether any of the known modulators of NIK abundance were dysregulated in p65 KO MEFs. The molecular components that reduce the basal abundance of NIK form the TRAF2-TRAF3-cIAP1-cIAP2 E3 ubiquitin ligase complex (20) . We found that the amounts of TRAF2, TRAF3, cIAP1, and cIAP2 were similar or increased in p65 KO MEFs compared to those in wild-type cells (Fig.  6E) , consistent with a potential role for noncanonical NF-kB signaling in regulating the abundance of TRAF3 (37) . Because birc3 (which encodes cIAP2) is a classical NF-kB target gene (38), we assessed birc3 transcripts in p65 KO MEFs and found that they were present in similar amounts in p65 KO and wild-type MEFs ( fig. S9A ). In addition, birc3 expression was intact in NEMO KO MEFs, suggesting that disruption of the IKK complex did not affect basal birc3 expression. We therefore conclude that cIAP2 is not the molecular target of classical NF-kB signaling that controls basal NIK abundance. The amounts of cIAP1, TRAF2, and TRAF3 proteins were similar, if not increased, among the cell lines that we studied (fig. S9B), and TRAF3 stability was unaffected by loss of classical NF-kB activity ( fig. S9C ). In addition, exogenous NIK physically associated with endogenous TRAF3, TRAF2, and cIAP1 even in the absence of NEMO or p65 ( fig. S10 ). Together, these results suggest that aberrant NIK detected in the absence of NEMO, IKKb, or p65 does not arise because of changes in the currently known NIK regulatory machinery.
Our results indicated that the transcriptional activity of classical NF-kB was required to actively suppress basal noncanonical NF-kB signaling, because loss of p65 enabled the stabilization of NIK and the processing of p100 in resting cells, similar to the case when the upstream signaling components NEMO or IKKb are lost (Figs. 1, 2, and 4) . We therefore hypothesized that enforced classical NF-kB activity could rescue aberrant noncanonical NF-kB signaling in NEMO KO MEFs. To test this, we transduced NEMO KO MEFs with retrovirus containing control MigR1 plasmid alone or MigR1 encoding wild-type IKKb to generate stable cell lines overexpressing IKKb. Overexpression of wild-type IKKb alone was sufficient to drive classical NF-kB transcriptional activity, even in the absence of NEMO (Fig. 6F) . Furthermore, we observed reduced NIK amounts and decreased processing of p100 in NEMO KO MEFs that overexpressed wild-type IKKb compared to control cells (Fig. 6G) . Collectively, these results confirm that classical NF-kB transcriptional activity is required to actively prevent the accumulation of NIK and thus to prevent noncanonical NF-kB signaling in resting cells.
NEMO-ID mutants do not restore regulation of NIK abundance
Our studies in MEFs revealed a previously uncharacterized level of crosstalk between classical NF-kB signaling and the regulation of NIK abundance. Because of the scarcity of patient-derived material, we could not definitively determine the status of basal NIK abundance in NEMO-ID PBMCs. Thus, we reconstituted NEMO KO MEFs with the hyper-IgAassociated Q403X and C417R mutant NEMO proteins to further evaluate the effects of NEMO-ID mutations on noncanonical NF-kB signaling. Unlike the NEMO 86-419 truncation mutant that cannot bind to IKKa or IKKb ( fig. S4 ), NEMO Q403X and NEMO C417R each associated with the IKKs to form a heterotrimeric IKK complex in reconstituted cells (Fig. 7A) . Despite being able to form IKK complexes, neither NEMO Q403X nor NEMO C417R rescued TNF-a-induced NF-kB activation in NEMO KO MEFs, confirming that these mutants ablate classical IKK activity (Fig. 7B) . Whereas normal regulation of NIK abundance was restored in NEMO WT MEFs, increased amounts of NIK were maintained in NEMO KO MEFs reconstituted with either NEMO Q403X or NEMO C417R (Fig. 7C) . We further generated an additional NEMO-ID mutant MEF cell line containing a NEMO variant (NEMO L153R ) with a mutation in a distinct functional domain of the protein. Previous reports showed that this mutation does not enable classical NF-kB signaling (30, 39) , and we found that NEMO L153R failed to restore control of basal NIK abundance in transfected NEMO KO cells (Fig. 7C) . These findings suggest that the ability of NEMO to constitute part of the IKK complex is insufficient to properly regulate the noncanonical NF-kB pathway. Rather, a signal-competent IKK complex and intact classical NF-kB activity are essential to maintain the quiescent state of the noncanonical NF-kB pathway.
DISCUSSION
Our findings reveal an essential role for the NEMO-dependent classical NF-kB pathway in inhibiting the basal activity of the noncanonical NF-kB pathway. We showed that naturally occurring NEMO-ID mutations prevented inhibition of the noncanonical NF-kB pathway by the classical IKK complex. Patients with hypomorphic mutations in ikbkg exhibit a complex immunologic phenotype that results in widespread immunodeficiency (40) . The clinical presence of enhanced amounts of serum IgA in patients with NEMO-ID is intriguing because noncanonical NF-kB signaling directly controls class switching to the IgA isotype (28) . B cellspecific deletion of the gene encoding TRAF-associated NF-kB activator (TANK)-binding kinase 1 (TBK1) in mice leads to NIK stabilization and nephritis because of prolonged noncanonical signaling and increased amounts of IgA (28) . We found that unstimulated PBMCs from patients with NEMO mutations associated with hyper-IgA syndrome exhibited enhanced processing of p100, supporting the existence of a defect in the basal regulation of noncanonical NF-kB. Thus, we conclude that in a subset of NEMO-ID patients, defective activation of classical NF-kB signaling leads to the increased basal activity of the noncanonical NF-kB pathway. This finding provides a potential mechanism for the aberrant class switching that occurs in NEMO-ID, and represents a demonstration of the dysregulated noncanonical NF-kB signaling pathway in humans.
To investigate the mechanism underlying defective regulation of noncanonical NF-kB signaling, we used a panel of IKK-deficient MEF cell lines. In light of the prevailing model in which the IKK complex plays no role in the noncanonical NF-kB pathway (19), we were surprised to detect enhanced p100 processing in cells lacking NEMO or IKKb. In both cases, p100 processing was further enhanced by stimulation of the cells with LIGHT or LTbR antibody; however, in some instances, p52 amounts in NEMO-or IKKb-deficient cells appeared to be maximal. Moreover, the ratio of p52 to p100 in untreated NEMO KO MEFs was similar to that in maximally stimulated wild-type MEFs, suggesting that noncanonical signaling was fully active in the absence of NEMO. These findings are consistent with earlier studies (17, 18, 41) ; however, the catalytically active IKKa and enhanced basal p100 processing previously observed in NEMO KO cells have never been highlighted or addressed.
In seeking to determine the mechanism for enhanced p100 processing, we found that NIK abundance was substantially increased in resting cells lacking either NEMO or IKKb. Consistent with active p100 processing, the NIK protein detected in the absence of NEMO or IKKb resembled that induced by stimulation of wild-type MEFs with LIGHT or LTbR antibody. This result further corroborates the finding that noncanonical NF-kB signaling is basally active in these cells. We also found that NEMO and IKKb must physically interact, and that the catalytic activity of IKKb is required for regulation of basal NIK abundance. Hence, we conclude that, in resting cells, the intact and catalytically competent IKK complex maintains basal amounts of NIK and prevents the constitutive processing of p100 to generate p52.
Because the limited availability of clinical samples precluded a definitive determination of the status of NIK in PBMCs from patients with NEMO-ID, we established stable MEF cell lines that expressed pathological ikbkg mutations. In each case, the NEMO-ID mutants assembled with endogenous IKKa and IKKb to form a heterotrimeric IKK complex; however, consistent with previous studies, these complexes were unable to activate classical NF-kB signaling (42, 43) . Furthermore, we detected increased amounts of NIK protein in the NEMO-mutant cells. Hence, our data establish that functional mutations of NEMO that do not prevent IKK complex assembly alter the basal regulation of the noncanonical NF-kB pathway. We have only been able to assess this defect retrospectively in clinical samples, but our studies support future assessment of noncanonical NF-kB signaling in NEMO-ID patients. Moreover, these accumulated findings prompt a reevaluation of the current view that the IKK complex plays no role in regulating noncanonical NF-kB signaling. Unlike the stable NIK protein present in IKKa KO MEFs, the NIK protein that we detected in IKKb-or NEMO-deficient cells was phosphorylated. Feedback inhibition of NIK requires its IKKa-mediated phosphorylation (27) , which we showed to occur in the absence of NEMO binding to IKKa. Signal-induced p100 processing was also intact in IKKa-deficient cells reconstituted with an IKKa mutant that cannot bind to NEMO. Our findings therefore provide definitive biochemical support for the tenet that IKKa alone, independent of its association with the IKK complex, is sufficient to both activate the processing of p100 and inhibit noncanonical NF-kB signaling.
We found that NIK was basally phosphorylated in cells lacking NEMO or IKKb to the same extent as it was in stimulated wild-type cells. This led us to question whether the heterotrimeric IKK complex "licenses" IKKamediated turnover of NIK protein, enabling phosphorylated NIK to accumulate in NEMO-or IKKb-deficient cells. Our experiments with cycloheximide revealed that although NIK turnover in both resting and stimulated IKKa KO MEFs was defective, turnover occurred normally in cells lacking IKKb or NEMO. We thus conclude that the IKK complex does not regulate IKKamediated NIK turnover, but instead plays an obligate role in limiting the basal pool of newly synthesized NIK. In support of this interpretation, we found that the stable NIK in TRAF3 KO MEFs (23) was phosphorylated and turned over normally. Hence, basal NIK in cells lacking the intact IKK complex was similar to newly synthesized NIK that had escaped the TRAF2-TRAF3-cIAP1-cIAP2 regulatory machinery. These findings also confirm that TRAF3 plays no role in the IKKa-driven degradation of active NIK and imply that a previously uncharacterized regulatory mechanism is responsible for this phase of deactivation of noncanonical NF-kB signaling.
IKKa (27) and TBK1 (28) phosphorylate NIK, leading to its controlled turnover. Although our results do not support a role for classical NF-kB signaling in inhibition of the noncanonical NF-kB pathway, NIK is clearly subject to multiple layers of regulation by IKK or IKK-like kinases. We have not directly ruled out a role for a previously uncharacterized catalytic function by the heterotrimeric IKK complex; however, our studies in p65 KO MEFs revealed that classical NF-kB activity was required to maintain undetectable amounts of NIK in resting cells. To accomplish this, classical NF-kB signaling may regulate a specific gene or genes whose products regulate the basal amount of NIK. Likely candidate genes include those encoding TRAF2, TRAF3, the cIAPs, or OTUD7B, a deubiquitinase that promotes TRAF3 stability (44) . However, we found that, compared to those in wild-type MEFs, the amounts of TRAF2, TRAF3, cIAP1, and cIAP2 were similar or somewhat increased among all of the MEF cell lines that we tested. Furthermore, overexpressed NIK associated with endogenous TRAF3, TRAF2, and cIAP1 in wild-type MEFs and in cells lacking NEMO or p65, suggesting that defective classical NF-kB signaling does not prevent the basal NIK regulatory complex from forming in these cells.
Mounting evidence has shown that cIAP1 and cIAP2 are functionally redundant in their roles as E3 ubiquitin ligases that lead to NIK degradation; individual knockout cells must be complemented with small interfering RNA or Smac mimetics to degrade the other cIAP and stabilize NIK (24, 25, 45) . We observed similar amounts of birc3 mRNA among p65 KO and NEMO KO MEFs compared to wild-type MEFs, confirming the presence of this E3 ubiquitin ligase that is required for regulation of NIK abundance. Our data further suggest that OTUD7B (44) is not involved in basal NIK regulation by the classical IKK complex, because TRAF3 stability was unaffected by the loss of NEMO or IKKb. We therefore surmise that classical NF-kB signaling drives the expression of a unique gene or set of genes whose products are involved in regulating noncanonical NF-kB signaling. Although the exact gene targets remain to be determined, our results establish an obligate role for classical NF-kB activity to facilitate the quiescent state of noncanonical NF-kB in unstimulated cells.
In conclusion, we demonstrated that classical NF-kB signaling limits the size of the basal pool of NIK, identifying a previously uncharacterized function for the IKK complex in inhibiting the noncanonical NF-kB pathway. Disruption of the heterotrimeric IKK complex through genetic loss of NEMO or IKKb, catalytic inactivity of IKKb, failure to form a heterotrimeric IKK complex, or naturally occurring mutations in NEMO that prevent classical NF-kB activity resulted in the increased abundance of NIK and aberrant noncanonical NF-kB signaling. Collectively, these findings establish a model of NF-kB pathway crosstalk that regulates basal noncanonical signaling, and provide a potential mechanism to explain the perplexing hyper-IgA phenotype observed in patients with NEMO-ID.
MATERIALS AND METHODS
Cell lines and culture NIH 3T3 MEFs were purchased from the American Type Culture Collection. The 3T8 Jurkat T cell line has been described elsewhere (33) and was previously mutagenized to generate the NEMO KO cell line 8321 (33) . These 8321 cells were transfected with plasmid encoding full-length NEMO to generate 8321
WT cells (30) . All fibroblasts and Plat-E cells were cultured in Dulbecco's modified Eagle's medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen), 2 mM L-glutamine, penicillin (50 U/ml), and streptomycin (50 U/ml). Jurkat T cells were cultured in RPMI medium (Invitrogen) supplemented with 10% FBS, 2 mM L-glutamine, penicillin (50 U/ml), and streptomycin (50 U/ml). Cells were passaged with 0.25% trypsin (Invitrogen). Unless otherwise noted, cells were stimulated with TNF-a (10 ng/ml), LIGHT (100 ng/ml), or LTbR antibody (300 ng/ml) when they reached 80% confluence.
Patient samples
Patient PBMCs were obtained with parental consent and with approval by the Children's Hospital Committee on Clinical Investigation, Children's Hospital Boston, as described previously (29) . Clinical presentations and immunological findings from these patients were previously reported (29, 30) .
Reagents
Recombinant human TNF-a and LIGHT were purchased from R&D Systems, and the agonistic antibody against LTbR (clone 5G11) was from Abcam. Antibodies against NIK, histone H3, and murine p100/p52 were purchased from Cell Signaling Technology. NEMO antibody was purchased from MBL International. Anti-human p100/p52 was from Millipore. Antibodies against NEMO, IkBa, IKKa, TRAF3, TRAF2, cIAP-2, and TBK1 were purchased from Santa Cruz Biotechnology. IKKa and IKKb antibodies were purchased from Imgenex. Monoclonal cIAP1 antibody was purchased from Enzo Life Sciences. a-Tubulin antibody (T5168), protein G-Sepharose beads, anti-FLAG (M2) beads, and N-carbobenzyloxy-L-leucyl-L-leucyl-Lleucinal (MG132) were from Sigma-Aldrich. Fugene 6 transfection reagent was from Promega. Horseradish peroxidase-conjugated secondary antibodies and normal rabbit serum were from Jackson ImmunoResearch. Fluorescently labeled secondary antibodies were purchased from LI-COR Biosciences. Cycloheximide was purchased from Calbiochem, and l-phosphatase was from New England Biosciences.
Generation of stable cell lines
All cloning procedures were performed with the Pfu Turbo PCR procedure, as previously described (35) . Briefly, complementary DNAs (cDNAs) encoding full-length wild-type and DNBD IKKa (encoding amino acid residues 1 to 734 lacking the NEMO-binding domain) were subcloned into the MigR1 vector, which contains an internal ribosomal entry site (IRES)-green fluorescent protein (GFP) (Addgene plasmid #27490) (46) . Platinum-E retroviral packaging cells were transfected with these vectors with Fugene 6, and retrovirus-containing supernatants were collected. IKKa KO MEFs were retrovirally transduced as previously described (35) (32) . Twenty-four hours after transfection, cells were selected with puromycin (1 mg/ml). Retrovirus-containing supernatants were collected and used to transduce IKKb KO MEFs. To reconstitute p65 KO MEFs, a cDNA encoding full-length p65 was cloned into the pBABE retroviral vector. Phoenixecotropic retroviral packaging cells were transfected with pBABE-p65 WT and selected with puromycin (1 mg/ml). Retroviral supernatants were used as described earlier to transduce p65 KO MEFs.
NIK overexpression
Wild-type, NEMO KO , and p65 KO MEFs were transiently transfected with the pFLAG-CMV2 NIK plasmid with a 3:2 ratio of Fugene 6 to DNA. Briefly, cells were transfected in 100-mm dishes. Twenty-four hours later, cells were harvested for immunoprecipitation with anti-FLAG (M2) beads and Western blotting analysis.
Western blotting analysis and immunoprecipitations
Cells were harvested on ice in lysis buffer consisting of 150 mM NaCl, 50 mM tris-HCl (pH 7.5), 1% Triton X-100, and complete protease inhibitors (Roche). Proteins were resolved by SDS-polyacrylamide gel electrophoresis and were transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore). Unless otherwise noted, the Western blots presented in the figures are from one experiment and are representative of four independent experiments. PVDF membranes were developed with enhanced chemiluminescence. Immunoprecipitations were performed with 500 mg of total protein lysate, as previously described (35) .
Luciferase reporter assays
Cells were transfected with 500 ng of total DNA [PBIIx kB firefly luciferase (FFL) and pRL TK Renilla luciferase (RL) in a 10:1 ratio] as previously described (31) . Twenty-four hours after transfection, cells were treated with TNF-a (10 ng/ml), lysed, and analyzed for dual luciferase activity as described previously (12) . Mean relative luciferase units (FFL:RL) were determined from at least three independent experiments, unless otherwise noted, and P values were calculated with a Student's twotailed t test or one-way ANOVA in Prism software.
Preparation of nuclear and cytosolic extracts
Cells were scraped from dishes into phosphate-buffered saline at 4°C and pelleted by centrifugation at 425g for 10 min. Cell pellets were processed for nuclear extraction as described previously (32) . Lysates were analyzed by Western blotting as described earlier.
Isolation of mRNA and quantitative RT-PCR analysis
RNA was isolated with the RNase Easy Spin Kit (Qiagen) according to the manufacturer's instructions. Samples were subjected to on-column deoxyribonuclease digestion. Semiquantitative amplification of target genes was performed with Power SYBR Green (Applied Biosystems) according to the manufacturer's instructions. PCR products were generated in quadruplicate, and their abundance was normalized to that of the actb product (which encodes b-actin) with the ABI 7500 Real-Time PCR system. Relative quantitation (RQ) was derived from the difference in cycle threshold (C t ) between the gene of interest and actb with the equation RQ = 2
−DDCt
and was analyzed with SDS v1.3 software. PCR product specificity was confirmed by performing a dissociation curve with each experiment. The map3k14 QuantiTect Primer Assay was purchased from Qiagen; the actb primer pair (5′-ACCCACACTGTGCCCATCTA-3′ and 3′-ATCGGAA-CCGCTCGTTGC-5′) and the birc3 primer pair (5′-CTGGCCAAAG-CAGGCTTCTACTAC-3′ and 3′-CACGCTACCCTTTGACTCGTTGAC-5′) were purchased from Integrated DNA Technologies.
Protein quantification and statistical analyses
Western blots were quantified with background subtraction with the LI-COR Odyssey imaging system or ImageJ software [National Institutes of Health (NIH)]. For each method, the intensity of the band of interest was normalized to its corresponding control band (a-tubulin, b-actin, or histone H3). Each value was normalized relative to the unstimulated (wildtype) control, and relative arbitrary units are shown. Statistical analyses of at least three independent experiments were performed with Prism software. A Student's two-tailed t test or one-way ANOVA with Dunnett's post-test to the wild-type control was performed for all data sets.
SUPPLEMENTARY MATERIALS
www.sciencesignaling.org/cgi/content/full/7/311/ra13/DC1 Fig. S1 . Basal and anti-LTbR-induced p100 processing in IKKa-and NEMO-deficient cells. 
